Stay in touch
Prime news from our network.
Stay in touch
Prime news from our network.
A characteristic feature of BIO-Europe is the high density of decision-makers and investors who arrange meetings in advance via a partnering platform in order to expand business relationships, explore opportunities for cooperation and expand their network. The aim of the Saxon joint stand was to present innovative projects and Saxon expertise in the field of life sciences and to promote international exchange. And this was a complete success.
Strong dialogue and valuable contacts
The joint stand in Saxony attracted numerous visitors from all over the world, including interested parties from the USA, Great Britain, Japan, Pakistan, Israel, Great Britain, South Korea and New Zealand. „Among other things, we had valuable discussions with bacteriophage innovators from all over the world, with whom we would like to collaborate as part of our future transfer and research centre“, says André Hofmann, Managing Director of biosaxony. Dr Carola Graf, Head of Biotechnology at biosaxony, added: „Another focus of our trade fair presence was on the field of radiopharmacy. With the new Saxon radiopharmaceutical cluster nukliD® we want to promote corresponding innovations. Saxony offers the ideal conditions for this with its excellent research infrastructure and highly qualified specialists.
Visitors were also interested in the presentation of MEDICAL FORGE Leipzig, an accelerator for young innovative medical technology companies on the BioCity Campus Leipzig. MEDICAL FORGE makes it easier for international start-ups and companies to enter the German healthcare market and offers them support in areas such as regulatory advice, technology promotion and market access. Our stand was a real magnet for medtech companies, even though the focus of BIO-Europe is more on pharmaceuticals and therapeutics," emphasises Simone Haubner, COO of MEDICAL FORGE.
Community spirit at the Saxon stand
Among others, the Dresden-based company qualitype GmbH, a software specialist for digital laboratory processes, presented itself at the stand. Dr Isabell Hilger, responsible for business development at qualitype, emphasised the extraordinary synergy and networking at the Saxon stand: "Many of the new contacts made were of interest to several companies, so that discussions could be dynamically expanded and everyone involved could benefit from the growing network.
Open exchange and inspiring atmosphere
Dr. Anja Rösler, Head of Medical Technology and Company Advisor at BIO CITY LEIPZIG and representative of LEVG – Leipziger Entwicklungs- und Vermarktungsgesellschaft, confirmed this impression and added that „this year the life science industry seemed to meet the current challenges with an ‚extra‘ openness and informal exchange”. „The supporting programme and the relaxed atmosphere certainly contributed to this, especially the inspiring evening programme, such as the Swedish dinner at the site of the Nobel Prize awards.“
Networking and internationalisation
The Saxony Economic Development Corporation (WFS) was also active at the stand. Barbara Weigert, Project Manager Inward Investment at WFS, explained: "At the trade fair, we were able to arrange potential research contacts, provide information about funding programmes and discuss specific steps with interested companies on how they can integrate themselves into the Saxon economic system. In addition, biosaxony partner Rechtsanwaltsgemeinschaft LUTHER was available to answer questions on German framework conditions.
Weigert also attached particular importance to expanding the company's international presence: "We have finalised future events in Switzerland and Japan in order to further position Saxony internationally as a location for biotechnology and life sciences.
Leipzig as a future location for biotechnology The city of Leipzig was also represented at the stand with its location marketing initiative „Leipzig for LifeChangers“ and recommended itself as an international transfer location for innovative cell and gene therapies, lab-on-chip diagnostics and as a pioneer in digital medicine. Ronny Schulz, Cluster Manager for Biotechnology and Healthcare of the City of Leipzig, announced: „In the near future, we will be presenting a variety of innovative technologies from Saxony at local specialist events such as the Leipzig Immune Oncology (LION) Conference, the AAV Meeting at the Fraunhofer Institute for Cell Therapy and Immunology (IZI), as well as the SACHS Forum and the 1st Annual European Biopharma Obesity Innovation Forum. Also on the agenda for the coming year are the 25th anniversary of the Saxon Biotech Offensive and the 20th anniversary of the IZI and the Innovation Centre ICCAS at the University of Leipzig Medical School.“ The future Saxon venture capital fund GOLDTRACK Ventures, which specifically promotes innovative life science projects and thus lays the foundation for future-oriented developments, also aroused particularly great interest. Saxony is not only an attractive location for research, but also a reliable partner for sustainable financing solutions," emphasised biosaxony CEO Hofmann. „With the fund, Saxony is emphasising its strategic goal of becoming an even stronger player in the global biotechnology network.” said Hofmann.
Future funding from the venture capital fund GOLDTRACK
Looking forward to the next steps and BIO-Europe 2025
With a suitcase full of new contacts and exciting cooperation approaches, the Saxon cluster biosaxony is now looking forward to the coming months. We have gained valuable impetus for the further development of our projects and are looking forward to continuing some of these ideas in Vienna next year,
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.